BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$414M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$371M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$342M |
| 4 |
Microsoft
MSFT
|
+$339M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Salesforce
CRM
|
+$688M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$338M |
| 4 |
Eli Lilly
LLY
|
+$239M |
| 5 |
AGN
Allergan plc
AGN
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.86% |
| 2 | Consumer Discretionary | 6.16% |
| 3 | Healthcare | 5.91% |
| 4 | Communication Services | 5.19% |
| 5 | Financials | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRT
3726
BRT Apartments
BRT
$271M
| $6.91K | ﹤0.01% |
639
-2,435
| -79% | -$24.8K |
|
3727
Adecoagro
AGRO
$1.3B
| $6.91K | ﹤0.01% |
1,592
-317
| -17% | -$1.32K |
|
|
CBIO
3728
Crescent Biopharma
CBIO
$627M
| $6.87K | ﹤0.01% |
18
-87
| -83% | -$24.6K |
|
|
SBBP
3729
DELISTED
Strongbridge Biopharma plc.
SBBP
| $6.87K | ﹤0.01% |
1,817
-9,321
| -84% | -$27.9K |
|
3730
Orrstown Financial Services
ORRF
$855M
| $6.84K | ﹤0.01% |
464
-2,699
| -85% | -$36K |
|
3731
CarParts.com
PRTS
$48.6M
| $6.84K | ﹤0.01% |
+79
| New | +$4.21K |
|
|
KDNY
3732
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $6.83K | ﹤0.01% |
591
-3,722
| -86% | -$51.3K |
|
3733
Timberland Bancorp
TSBK
$358M
| $6.79K | ﹤0.01% |
373
-1,922
| -84% | -$33.5K |
|
3734
Avalo Therapeutics
AVTX
$1.02B
| $6.79K | ﹤0.01% |
1
-1
| -50% | -$7.26K |
|
3735
Abeona Therapeutics
ABEO
$340M
| $6.76K | ﹤0.01% |
93
-558
| -86% | -$38.6K |
|
3736
Fennec Pharmaceuticals
FENC
$417M
| $6.75K | ﹤0.01% |
809
+747
| +1,205% | +$5.55K |
|
3737
Oak Valley Bancorp
OVLY
$289M
| $6.72K | ﹤0.01% |
530
-1,599
| -75% | -$21.3K |
|
3738
Colony Bankcorp
CBAN
$472M
| $6.67K | ﹤0.01% |
567
-1,719
| -75% | -$20K |
|
3739
Rockwell Medical
RMTI
$29.6M
| $6.66K | ﹤0.01% |
31
-148
| -83% | -$35K |
|
|
TBNK
3740
DELISTED
Territorial Bancorp Inc.
TBNK
| $6.61K | ﹤0.01% |
278
-2,163
| -89% | -$53.2K |
|
3741
Investar Holding Corp
ISTR
$426M
| $6.61K | ﹤0.01% |
456
-2,411
| -84% | -$30.7K |
|
|
HARP
3742
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $6.59K | ﹤0.01% |
40
-187
| -82% | -$29.2K |
|
|
TCS
3743
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $6.59K | ﹤0.01% |
136
-193
| -59% | -$7.45K |
|
|
SBBX
3744
DELISTED
SB One Bancorp Common Stock
SBBX
| $6.58K | ﹤0.01% |
334
-2,211
| -87% | -$38.4K |
|
3745
Mid Penn Bancorp
MPB
$974M
| $6.56K | ﹤0.01% |
356
-1,791
| -83% | -$33.7K |
|
3746
OptimizeRx
OPRX
$164M
| $6.51K | ﹤0.01% |
500
-3,779
| -88% | -$41.1K |
|
3747
Acacia Research
ACTG
$448M
| $6.47K | ﹤0.01% |
1,582
-12,879
| -89% | -$37.3K |
|
3748
Lakeland Industries
LAKE
$119M
| $6.44K | ﹤0.01% |
+287
| New | +$4.7K |
|
3749
Sutro Biopharma
STRO
$347M
| $6.43K | ﹤0.01% |
83
-255
| -75% | -$24.5K |
|
|
STR
3750
DELISTED
Sitio Royalties
STR
| $6.43K | ﹤0.01% |
503
-2,466
| -83% | -$25.9K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2020 Portfolio in Review
As of Q2 2020, BNP Paribas Financial Markets held 4,480 positions worth $56.7B, up 16% from $48.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BNP Paribas Financial Markets withdrew a net $2.34B in Q2 2020, closing 174 positions and reducing 2,678 holdings. Its most notable exit was Allergan plc, an estimated $225M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in State Street SPDR Portfolio Intermediate Term Corporate Bond ETF worth $35.2M.
- BNP Paribas Financial Markets's largest Q2 2020 buy was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF: 962,483 shares worth $35.2M.
- BNP Paribas Financial Markets added most to Apple in Q2 2020, an estimated $414M increase.
- BNP Paribas Financial Markets's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Allergan plc in Q2 2020, selling an estimated $225M.
- BNP Paribas Financial Markets's ten largest holdings make up 20% of its $56.7B portfolio in Q2 2020.
- BNP Paribas Financial Markets opened 164 new positions and closed 174 in Q2 2020.
- BNP Paribas Financial Markets's portfolio value rose 16% quarter-over-quarter to $56.7B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2020, filed 6 Aug 2020.